#241 (Mar. 14, 2026) 'Drug Cycling in Cancer Care: What It Is and Why It’s Critical': IMA (formerly FLCCC) Weekly Update

#241 (Mar. 14, 2026) 'Drug Cycling in Cancer Care: What It Is and Why It’s Critical': IMA (formerly FLCCC) Weekly Update

From IMA (Formerly FLCCC Alliance) by by the IMA (Formerly FLCCC Alliance)

March 19, 2026 · 1h 16m

About this episode

This episode discusses the importance of drug cycling in cancer care and its impact on treatment outcomes.

What happens when a cancer treatment stops working the way it once did? As tumors adapt and resistance develops, treatment strategy can become a critical part of improving outcomes. Sign up for weekly webinars: Weekly Webinars - Independent Medical Alliance In this episode, Dr. Ryan Cole, IMA Head of Medical & Scientific Affairs, speaks with Dr. Paul Marik, IMA Chief Scientific Officer, about the role of drug cycling in cancer care and why it may be essential for patients facing complex treatment decisions. They cover: • What drug cycling is and how it is used in cancer care • Why changing therapies over time may matter • How tumor adaptation and resistance affect treatment response • What timing, sequencing, and strategy can mean in practice Dr. Marik’s new cancer guides and how they may help support patients and families This conversation offers a practical look at why cancer treatment should not always remain fixed and how thoughtful changes in therapy may help shape better outcomes. Aired Wednesday, March 18, 2026. Also: • Donate: https://imahealth.org/donate/ • Follow: https://imahealth.org/contact/ • Webinar: https://imahealth.org/category/weekly-webinars/ • Treatment…

More episodes of IMA (Formerly FLCCC Alliance)

Explore listener stats, chart rankings, contacts and more on the IMA (Formerly FLCCC Alliance) podcast page.